These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7152077)

  • 1. Improvements in the rheologic properties of blood induced by medium-term treatment with buflomedil in diabetic patients.
    Coccheri S; Palareti G; Poggi M; Tricarico MG
    J Int Med Res; 1982; 10(6):394-8. PubMed ID: 7152077
    [No Abstract]   [Full Text] [Related]  

  • 2. [Decrease of blood viscosity induced by buflomedil in healthy volunteers].
    Craveri A; Tornaghi G; Paganardi L; Ranieri R; Di Bella M
    Minerva Cardioangiol; 1988; 36(7-8):357-60. PubMed ID: 3211334
    [No Abstract]   [Full Text] [Related]  

  • 3. The influence of buflomedil on blood viscosity parameters in insulin-dependent diabetic patients: a preliminary study.
    Van Acker K; Rillaerts E; De Leeuw I
    Biomed Pharmacother; 1989; 43(3):219-22. PubMed ID: 2775859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of buflomedil against exercise-induced reductions in regional erythrocyte deformability of patients with peripheral arterial disease.
    Guerrini M; Acciavatti A; Materazzi M; Rossi C; Del Bigo C; Forconi S; Di Perri T
    J Int Med Res; 1982; 10(6):387-93. PubMed ID: 7152076
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of long-term treatment with suloctidil on blood viscosity, erythrocyte deformability and total fibrinogen plasma levels in diabetic patients.
    Roncucci R; De Hertogh R; Dormandy JA; Doumont J; Gurewich V; Lambelin G; Lansen J; Rottiers R; Souridis E; Van Stalle F; Versee L
    Arzneimittelforschung; 1979; 29(4):682-4. PubMed ID: 582768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of buflomedil hydrochloride on the rheological properties of the blood in chronic cerebrovascular diseases].
    Lombardini R; Ciuffetti G; Paltriccia R; Scarponi AM; Savastano V; Palazzetti D; Mercuri M; Parnetti L
    Ric Clin Lab; 1989; 19 Suppl 1():117-9. PubMed ID: 2629069
    [No Abstract]   [Full Text] [Related]  

  • 7. [Viscosity of the blood, fibrinogen and hematocrit in diabetes mellitus].
    Mosora N; Baciu T; Vincze J
    Med Interna (Bucur); 1972 Jan; 24(1):89-93. PubMed ID: 5021766
    [No Abstract]   [Full Text] [Related]  

  • 8. Failure of pentoxifylline or cilostazol to improve blood and plasma viscosity, fibrinogen, and erythrocyte deformability in claudication.
    Dawson DL; Zheng Q; Worthy SA; Charles B; Bradley DV
    Angiology; 2002; 53(5):509-20. PubMed ID: 12365857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Blood viscosity and erythrocyte deformability in diabetic retinopathy].
    Melli M; Poggi M; Codeluppi L; Baraldi P; Torlai F; Peduzzi M
    Ric Clin Lab; 1983; 13 Suppl 3():371-4. PubMed ID: 6673016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rheologic observations on blood viscosity in diabetes mellitus].
    Alberto S; Biasci R; Picco S; Dughera L
    Minerva Cardioangiol; 1977; 25(7-8):621-8. PubMed ID: 927654
    [No Abstract]   [Full Text] [Related]  

  • 11. [Blood rheological disorders in diabetes mellitus].
    Galenok VA; Go stinskaia EV; Dikker VE
    Ter Arkh; 1982; 54(10):128-32. PubMed ID: 6758167
    [No Abstract]   [Full Text] [Related]  

  • 12. Tissular oxygenation and venoarteriolar reflex disturbances in diabetes mellitus: vasoregulator effect of Buflomedil.
    Le Devehat C; Khodabandehlou T; Vimeux M
    Clin Hemorheol Microcirc; 1999; 21(3-4):329-34. PubMed ID: 10711765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant effect of ABO blood groups on the aggregation of red cells in patients with diabetes mellitus. Role of fibrinogen and serum proteins.
    Dintenfass L
    Microvasc Res; 1974 May; 7(3):326-41. PubMed ID: 4829266
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabolic effects of buflomedil hydrochloride.
    Briguglio F; Di Marco V; Circosta C; Padovano I; Ragusa S; Saija A; Briguglio E
    J Int Med Res; 1985; 13(3):131-58. PubMed ID: 2989026
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical and hemorheological effects of buflomedil in diabetic subjects with intermittent claudication.
    Diamantopoulos EJ; Grigoriadou M; Ifanti G; Raptis SA
    Int Angiol; 2001 Dec; 20(4):337-44. PubMed ID: 11782701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of the vasoactive drug buflomedil in arterial occlusive disease].
    Racenberg J; Intaglietta M; Messmer K
    Fortschr Med; 1982 Nov; 100(41):1926-30. PubMed ID: 7152426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies of the blood viscosity in diabetics].
    Bollinger A; Berchtold P; Berger W
    Praxis; 1969 Sep; 58(35):1104-7. PubMed ID: 5820313
    [No Abstract]   [Full Text] [Related]  

  • 18. [Blood rheology in diabetic patients and its change after combined traditional Chinese and western medicine treatment].
    Zhu CY
    Zhong Xi Yi Jie He Za Zhi; 1983 May; 3(3):143-5. PubMed ID: 6225545
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of buflomedil in a group of patients with chronic peripheral arterial diseases. Clinical and hemorheological evaluation.
    Mozzi E; Chiurazzi D; Spinola A; Annoni F; Germiniani R
    J Int Med Res; 1985; 13(6):317-21. PubMed ID: 4076530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Flowmetric, thermometric and rheologic studies in obliterating arterial diseases of the lower extremities treated with buflomedil].
    Dorigo B; Raspanti D; Trapani M; Albanese B; Cameli AM; Digiesi V
    Minerva Med; 1985 Feb; 76(7):269-75. PubMed ID: 3974940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.